135 related articles for article (PubMed ID: 1106849)
1. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
Piel IJ; Perlia CP
Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
[TBL] [Abstract][Full Text] [Related]
3. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
Ehrlich CE; Einhorn L; Williams SD; Morgan J
Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
[No Abstract] [Full Text] [Related]
5. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.
Lacave AJ; Izarzugaza I; Antón Aparicio LM; Valle Pereda M; Gracia Marco JM; Buesa JM
Am J Clin Oncol; 1983 Feb; 6(1):35-8. PubMed ID: 6682284
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.
Kane R; Harvey H; Andrews T; Bernath A; Curry S; Dixon R; Gottlieb R; Kukrika M; Lipton A; Mortel R; Ricci J; White D
Cancer Treat Rep; 1979 Feb; 63(2):307-9. PubMed ID: 109201
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
Rossof AH; Coltman CA; Jones SE; Talley RW
Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).
Samson MK; Baker LH; Devos JM; Buroker TR; Izbicki RM; Vaitkevicius VK
Cancer Treat Rep; 1976 Jan; 60(1):91-7. PubMed ID: 63332
[TBL] [Abstract][Full Text] [Related]
10. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
11. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.
Yagoda A
Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226
[TBL] [Abstract][Full Text] [Related]
12. The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).
Vogl SE; Berenzweig M; Kaplan BH; Moukhtar M; Bulkin W
Cancer Treat Rep; 1979 Feb; 63(2):311-7. PubMed ID: 109202
[TBL] [Abstract][Full Text] [Related]
13. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
Takita H; Marabella PC; Edgerton F; Rizzo D
Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
[No Abstract] [Full Text] [Related]
14. cis-Dichlorodiammineplatinum(II) in childhood cancer.
Freeman AI; Ettinger LJ; Brecher ML
Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
[TBL] [Abstract][Full Text] [Related]
15. cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E.
Ghanta VK; Jones MT; Woodard DA; Durant JR; Hiramoto RN
Cancer Res; 1977 Mar; 37(3):771-4. PubMed ID: 851480
[TBL] [Abstract][Full Text] [Related]
16. Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.
Drewinko B; Gottlieb JA
Cancer Chemother Rep; 1975; 59(3):665-73. PubMed ID: 1203891
[TBL] [Abstract][Full Text] [Related]
17. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
Muggia FM; Perloff M; Chia GA; Reed LJ; Escher GC
Cancer Chemother Rep; 1974; 58(6):919-26. PubMed ID: 4614899
[No Abstract] [Full Text] [Related]
20. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
Chary KK; Higby DJ; Henderson ES; Swinerton KD
Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
